Correction to: Bone Research https://doi.org/10.1038/s41413-023-00261-0, published online 19 April 2023
Following publication of this article,1 it is noticed that a sentence “and National Institute of General Medical Sciences of the National Institutes of Health P20GM125503 to IN” should be added to the Acknowledgement section.
The correction Acknowledgement should read:
Authors acknowledge Jeffrey A Kamykowski from the UAMS Digital Microscopy Core for assistance with image acquisition, and Stuart B. Berryhill, Julie Crawford, Richard D. Peek from the UAMS Bone Biomechanics, Histology and Imaging Core of the Center for Musculoskeletal Disease Research (Center of Biomedical Research Excellence COBRE), and Jesus Delgado-Calle for critical reading of the manuscript. Abaloparatide (ABL) was provided by Gary Hattersley and Beate Lanske from Radius Health, Inc.
This research was supported by the Veterans Administration I01 BX002104 and IK6BX004596 to T.B.; R01-AR059357 to T.B.; UAMS College of Medicine Sturgis Endowment Grant to T.B.; ASH scholar award to S.M.; National Center for Advancing Translational Sciences of the National Institutes of Health KL2TR003108 and UL1TR003107 to A.Y.S.; and National Institute of General Medical Sciences of the National Institutes of Health P20GM125503 to I.N. The contents do not represent the views of the U.S. Department of Veterans Affairs, the United States Government and the National Institutes of Health.
The original article1 was updated.
References
Marino, S. et al. Reversal of the diabetic bone signature with anabolic therapies in mice. Bone Res. 11, 19 (2023).
Author information
Authors and Affiliations
Corresponding author
Additional information
The original article can be found online at https://doi.org/10.1038/s41413-023-00261-0.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Marino, S., Akel, N., Li, S. et al. Author Correction: Reversal of the diabetic bone signature with anabolic therapies in mice. Bone Res 11, 23 (2023). https://doi.org/10.1038/s41413-023-00266-9
Published:
DOI: https://doi.org/10.1038/s41413-023-00266-9
